Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians
Conclusions:
There are significant variations in the use of lipid-lowering drugs in Central and Eastern European countries; however, statin monotherapy predominates. Some physicians’ decisions are made without supporting evidence from clinical trials. There is still scope to improve preventive care of CVD.
Source: Journal of Cardiovascular Pharmacology and Therapeutics - Category: Cardiology Authors: Tomasik, T., Windak, A., Seifert, B., Kersnik, J., Kijowska, V., Dubas, K. Tags: Clinical Studies Source Type: research
More News: Atorvastatin Calcium | Bulgaria Health | Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Drugs & Pharmacology | Estonia Health | Health Management | Heart | Lipitor | Primary Care | Simvastatin | Statin Therapy | Study | Zivast | Zocor